|
DAY |
FRIDAY Sept 7, 2007 |
FRIDAY, September 7, 2007 |
|
Title |
Parallel Session 7: Small Bowel Transplant: Induction
Immunosuppression and Graft Immune Monitoring |
Parallel Session 8: Basic Science:Rejection |
|
8AM-1000 |
Lg Conf rm |
Sm conf Rm |
|
800-810A |
222 rATG VERSUS ALEMTUZUMAB AS A PRETREATMENT DEPLETING
AGENT AMONG INTESTINAL AND MULTIVISCERAL RECIPIENTS, L.
Martin, University of Pittsburgh Medical Center |
218 ROLE OFMyD88 DEPENDENT TLR SIGNALING PATHWAYS IN
SMALL BOWEL ALLOGRAFT REJECTION IN MICE Zheng Zhang,
Northwestern University |
|
810-820A |
214 IMPROVED OUTCOME AFTER INTESTINAL TRANSPLANTATION
WITH THE USE OF INDUCTION INTERLEUKIN-2 RECEPTOR
MONOCLONAL ANTIBODY THERAPY Johnny Hong, University of
California- Los Angeles |
106 DIFFERENTIAL PROLIFERATION OF THE INDIRECT AND
DIRECT PATHWAYS IN DONOR VS RECIPIENT LYMPHOID ORGANS
FOLLOWING INTESTINAL TRANSPLANATION Adnan Jaigirdar,
UCSF |
|
820-830A |
170 INDUCTION IMMUNOSUPPRESSION WITH RITUXIMAB AND ANTI-THYMOCITE
GLOBULIN IN INTESTINAL AND MULTIVISCERAL TRANSPLANTATION
Rodrigo Vianna, Indiana University |
216 POTENTIAL ROLE OF CCR6/Mip-3[alpha] MEDIATED
RECRUITMENT OF IMMATURE DENDRITIC CELLS INTO LAMINA
PROPRIA IN SMALL BOWEL ALLOGRAFT REJECTION Zheng Zhang,
Northwestern University |
|
830-840A |
197 CELLULAR DIFFERENTIATION AND REJECTION OF THE HUMAN
INTESTINAL TRANSPLANT Thomas Fishbein, Georgetown
University Hospital |
183 EFFECT OF BLOCKING THE ADHESION MOLECULE IN A SMALL
INTESTINAL TRANSPLANTATION MODEL Yoshiyuki Ihara Osaka
University Graduate School of Medicine, Japan |
|
840-850A |
121 INTERIM ANALYSIS OF STOOL CALPROTECTIN FOR
INTESTINAL ALLOGRAFT MONITORING Luciano Vargas,
University of Nebraska Medical Center |
219 SIGNALLING THROUGH INTESTINAL EPETHELIAL TNF
RECEPTORS IS DISPENSABLE IN REJECTION MEDIATED TIGHT
JUNCTION PERMEABILITY DYSFUNCTION Zheng Zhang,
Northwestern University, Feinberg School of Medicine |
|
850-900A |
116 CALPROTECTIN LEVELS IN SMALL BOWEL ALLOGRAFT
MONITORING: PRELIMINARY REPORT Edip Akpinar, University
of Miami- Jackson Memorial Hospital |
153 INDUCTION OF ANTI-STRESS PROTEIN ANTIBODIES AFTER
EXPERIMENTAL SEGMENTAL SMALL BOWEL TRANSPLANTATION
Ricardo Camprodon, King's College Hospital, UK |
|
900-910A |
36 CITRULLINE LEVELS ABOVE 13 SAFELY PREDICT ABSENCE OF
MODERATE OR SEVERE REJECTION AFTER INTESTINAL
TRANSPLANTATION Gennaro Selvaggi, University of Miami
Miller School of Medicine |
51 LONG-TERM n-3 PUFAs ADMINISTRATION COULD INHIBIT T
CELL ACTIVITY BY REDUCING CD154 EXPRESSION AND NF-[kappa]B
ACTIVATION IN A RAT MODEL OF SMALL BOWEL CHRONIC GRAFT
REJECTION Yousheng Li, Jinling Hospital, School of
Medicine, Nanjing University, China |
|
910-920A |
143 PRELIMINARY RESULTS USING THE IMMUNOKNOW ASSAY FOR
MONITORING OF INTESTINAL TRANSPLANT RECIPIENTS Debra
Sudan, University of Nebraska Medical Center |
166 COMBINATION THERAPY OF TACROLIMUS AND INFLIXIMAB
REDUCES THE INFLAMMATORY RESPONSE IN SMALL BOWEL
TRANSPLANTATION (SBTx) Thomas Pech, University of Bonn,
Germany |
|
920-930A |
136 PERIPHERAL CD4+ T CELL IMMUNE STATUS IN INTESTINAL
TRANSPLANTATION BY EVALUATION OF ATP PRODUCTION (CYLEX
IMMUKNOW ASSAY) Yide Jin, University of Miami |
57 BOMBESIN CAN MINIMIZE IMPAIRMENTS OF INTERSTITIAL
CELLS OF CAJAL INDUCED BY FK506 IN SMALL BOWEL
TRANSPLANTATION Koji Higuchi, Kyoto Prefectural
University of Medicine, Japan |
|
930-940A |
180 ACR MONITORING AFTER INTESTINAL TRANSPLANT: UTILITY
OF SEROLOGICAL MARKERS AND ZOOM VIDEOENDOSCOPY AS
SUPPORT OF CONVENTIONAL BIOPSY AND CLINICAL FINDINGS
Augusto Lauro, S. Orsola-Malpighi Hospital, University
of Bologna, Italy |
25 SIGNIFICANCE OF LYMPHOCYTE CROSSMATCH IN SWINE
INTESTINAL TRANSPLANTATION Makoto Hayashida, Graduate
School of Medical Sciences, Kyushu University, Japan |
|
940-950A |
22 TRANSLATION INTO THE CLINIC OF AN
EXPERIMENTALLY-PROVEN PRO-TREGULATORY PROTOCOL FOR
INTESTINAL TRANSPLANTATION. LONG-TERM RESULTS Jacques
Pirenne, University Hospitals Leuven, Belgium |
158 EFFECT OF ISCHAEMIC PRE-CONDITIONING ON THE
INDUCTION OF ALLOIMMUNE RESPONSES AFTER EXPERIMENTAL
SMALL BOWEL TRANSPLANTATION Ricardo Camprodon, King's
College Hospital, UK |
|
950-1000A |
31 INTERNATIONAL GRADING SCHEME FOR ACUTE REJECTION IN
SMALL BOWEL TRANSPLANTATION: 4 YEARS EXPERIENCE AT THE
UNIVERSITY OF MIAMI Hidenori Takahashi, University of
Miami |
167 EFFECT OF IMMUNOSUPPRESSIVE DRUGS ON THE
INFLAMMATION OF MUSCURALIS PROPRIA AND MOTOR DYSFUNCTION
AFTER SMALL BOWEL TRANSPLANTATION Jun Fujishiro,
University of Bonn, Germany |
|
1000-1010 |
Break |
Break |
|
1010-1020 |
Break |
Break |
|
1020-1030 |
Break |
Break |
|
Title |
Parallel Session 9: SMALL BOWEL TRANSPLANTATION:
COMPLICATIONS |
Parallel Session 10: Intestinal Failure/Intestinal
Rehabilitation |
|
1030-1230 |
Lg Conf rm |
Sm conf Rm |
|
1030-1040 |
227 RENAL FUNCTION IMPACTS OUTCOMES AFTER INTESTINAL
TRANSPLANTATION: A SINGLE CENTER REPORT OF RENAL EVENT
OUTCOMES Melissa Watson, David Geffen School of Medicine
at UCLA |
92 MANAGEMENT AND OUTCOMES OF CHILDREN REFERRED FOR
INTESTINAL REHABILITATION OR TRANSPLANT EVALUATION Anita
Nucci, Children's Hospital of Pittsburgh |
|
1040-1050 |
213 CHRONIC REJECTION AND RENAL FAILURE AS MAJOR CAUSES
OF DELAYED MORBIDITY/MORTALITY AFTER STEROID-FREE,
PRIMARY, PEDIATRIC SMALL BOWEL TRANSPLANTATION (SBTx)
Rakesh Sindhi, Children's Hospital of Pittsburgh |
142 IMPROVED SURVIVAL IN A MULTIDISCIPLINARY SHORT BOWEL
SYNDROME PROGRAM Biren Modi, Children's Hospital Boston |
|
1050-1100 |
221 ANALYSIS OF RECIPIENTS SURVIVING MORE THAN 1-YEAR
AFTER INTESTINAL TRANSPLANTATION: ASSESSMENT OF
PREDICTIVE FACTORS FOR SURVIVAL Robert Venick,
Dumont-UCLA Transplant Center |
120 EXPERIENCE WITH SURGICAL BOWEL LENGTHENING BY
BIANCHI OR STEP PROCEDURES IN ADULT PATIENTS Debra
Sudan, University of Nebraska Medical Center |
|
1100-1110 |
101 LATE COMPLICATIONS OF INTESTINAL TRANSPLANTATIONS AT
UNIVERSITY OF MIAMI Seigo Nishida, University of Miami |
74 ASSESSMENT AND OUTCOME OF PATIENTS WITH PROTRACTED
INTESTINAL FAILURE REFERRED FOR INTESTINAL
TRANSPLANTATION Solene Ganousse, Hopital Necker, Paris |
|
1110-1120 |
59 THE IMPACT OF BASILIXIMAB ON RENAL DYSFUNCTION (RDx)
AFTER INTESTINAL TRANSPLANTATION (ITx) IN CHILDREN Mara
Giovanelli, Birmingham Children's Hospital, UK |
141 IMPROVEMENT IN ENTERAL TOLERANCE FOLLOWING THE STEP
PROCEDURE IS NOT AGE-DEPENDENT: AN ANALYSIS OF THE
INTERNATIONAL STEP DATA REGISTRY Biren Modi, Children's
Hospital Boston |
|
1120-1130 |
60 THE IMPACT OF INDUCTION THERAPY ON BACTERIAL
INFECTIONS IN ADULT INTESTINAL AND MULTIVISCERAL
TRANSPLANTATION: A COMPARISON OF TWO DIFFERENT REGIMENS:
DACLIZUMAB VS ALEMTUZUMAB Takuya Kimura, S'Orsola-Malpighi
Hospital, Univ. of Bologna, Italy |
176 MULTIDISCIPLINARY APPROACH IN THE MAMAGEMENT OF
INTESTINAL FAILURE, Lopez-Santamaria Manuel, Hospital
Universitario La Paz, Spain |
|
1130-1140 |
110 INFECTIOUS ENTERITIS AFTER INTESTINAL
TRANSPLANTATION: AN UNDER-DIAGNOSED AND SIGNIFICANT
CAUSE OF POST-TRANSPLANT GRAFT DYSFUNCTION Khiet Ngo,
David Geffen School of Medicine at UCLA |
76 LONG-TERM OUTCOME OF CHRONIC INTESTINAL
PSEUDO-OBSTRUCTION (CIPO) PATIENTS Aurelien Amiot PMAD -
Hopital Beaujon, France |
|
1140-1150 |
196 A STRICT PROPHYLATIC AND PREEMPTIVE ANTIVIRAL
PROTOCOL IS HIGHLY EFFECTIVE IN PREVENTING
CYTOMEGALOVIRUS AND EPSTEIN BARR VIRUS-RELATED
COMPLICATIONS IN INTESTINAL TRANSPLANT RECIPIENTS
Sherilyn Gordon, David Geffen School of Medicine at UCLA |
41 THE BRITISH INTESTINAL FAILURE SURVEY (BIFS)- A
REGISTRY TO RECORD INCIDENCE, CAUSES AND OUTCOMES OF
CHILDHOOD INTESTINAL FAILURE Henry Gowen, Institute of
Child Health, Birmingham, UK |
|
1150-1200 |
58 CHRONIC RENAL FAILURE AFTER MULTIVISCERAL
TRANSPLANTATION Gustaf Herlenius, Sahlgrenska University
Hospital, Sweden |
188 PREDICTORS OF OUTCOME FOR INTESTINAL REHABILITATION.
A CENTER EXPERIENCE Kara Ventura, Columbia University
Medical Center |
|
1200-1210 |
148 ABSENCE OF ENTERIC BLOODSTREAM INFECTIONS (BSI)
AMONG SMALL BOWEL TRANSPLANT RECIPIENTS RECEIVING
SELECTIVE DECONTAMINATION OF THE DIGESTIVE TRACT (SDD)
Samuel Kocoshis, University of Cincinnati College of
Med, Cincinnati Children's Hospital |
228 TUFTING ENTEROPATHY OR INTESTINAL EPITHELIAL
DYSPLASIA: PRESENTATION AND OUTCOME FROM A SINGLE CENTER
SURVEY OF 26 PATIENTS Julie Salomon, Necker Hospital
University Paris 5, Paris |
|
1210-1220 |
48 INCIDENCE AND APPEARANCE OF POSTTRANSPLANT
LYMPHOPROLIFERATIVE DISORDERS (PTLD) IN INTESTINAL
TRANSPLANT RECIPIENTS. FOUR YEARS EXPERIENCE OF
MONITORING Elisa Gruppioni, S'Orsola-Malpighi Hospital,
Bologna University, Italy |
84 CHARACTERISTICS OF HOME PARENTERAL NUTRITION (HPN)
WEANING IN SHORT BOWEL (SBS) PATIENTS: A REVIEW OF 308
PATIENTS IN A SINGLE TERTIARY CARE CENTRE Aurelien Amiot,
PMAD, Beaujon Hospital, France |
|
1220-1230 |
226 EXPERIENCE WITH A PROTOCOL OF RESCUE IMMUNOTHERAPY
USING SIROLIMUS FOR CALCINURIN FAILURE AFTER INTESTINAL
TRANSPLANTATION Sherilyn Gordon, David Geffen School of
Medicine at UCLA |
70 APPLICABILITY AND OUTCOMES OF PATIENTS WITH
INTESTINAL FAILURE REFERRED AND TREATED WITH SURGERY OR
TRANSPLANTATION IN THE FIRST YEAR EXPERIENCE OF A SINGLE
SOUTH-AMERICAN CENTER Carolina Rumbo, Fundacion Favaloro |
|
1230-1240 |
Lunch |
Lunch |
|
1240-1250 |
Lunch |
Lunch |
|
1250-1300 |
Lunch |
Lunch |
|
1300-1310 |
Lunch |
Lunch |
|
1310-1320 |
Lunch |
Lunch |
|
1320-1330 |
Lunch |
Lunch |
|
Title |
Plenary Session 2: GALT Immune Regulation and
Dysregulation |
|
|
1330-1340 |
GALT - the Basics; Leo Lefrancois MD, Phd |
|
|
1340-1350 |
GALT - the Basics; Leo Lefrancois MD, PhD |
|
|
1350-1400 |
GALT - the Basics; Leo Lefrancois PhD |
|
|
1400-1410 |
Immunopathology of Crohn's Disease; Dan Podolsky MD |
|
|
1410-1420 |
Immunopathology of Crohn's Disease; Dan Podolsky MD |
|
|
1420-1430 |
Immunopathology of Crohn's Disease; Dan Podalsky MD |
|
|
1430-1440 |
Intestinal Ischemia and Reperfusion Injury; Yuan Zhai
PhD |
|
|
1440-1450 |
Intestinal Ischemia and Reperfusion Injury; Yuan Zhai
PhD |
|
|
1450-1500 |
Intestinal Ischemia and Reperfusion Injury; Yuan Zhai
PhD |
|
|
1500-1510 |
Immunopathology of Acute and Chronic Intestinal
Rejection; Ken Newell, MD, PhD |
|
|
1510-1520 |
Immunopathology of Acute and Chronic Intestinal
Rejection; Ken Newell, MD, PhD |
|
|
1520-1530 |
Immunopathology of Acute and Chronic Intestinal
Rejection; Ken Newell, MD, PhD |
|
|
1530-1540 |
Break |
Break |
|
1540-1550 |
Break |
Break |
|
1550-1600 |
Break |
Break |
|
Title |
Plenary Session 3: Debates - Hot Topics in SBT |
|
|
1600-1730 |
|
|
|
1600-1610 |
Debate#1: Induction Therapy; Pro ATG (Bond) vs Pro IL2RA
(Sudan) vs Pro Campath (Kato) |
|
|
1610-1620 |
Debate#1: Induction Therapy; Pro ATG (Bond) vs Pro IL2RA
(Sudan) vs Pro Campath (Kato); 18 min |
|
|
1620-1630 |
Debate#2: ReTransplantation; Pro (G. Mazariegos) vs Con
(W. Grant) 12 min |
OPEN |
|
1630-1640 |
Debate#3: Early ITx vs PN; Pro (Fishbein) vs Con
(Messing) 12 min |
|
|
1640-1650 |
|
|
|
1650-1700 |
16:45-17:30 ITA Business Meeting |
|
|
1700-1710 |
ITA Business Meeting |
|
|
1710-1720 |
ITA Business Meeting |
|
|
1720-1730 |
ITA Business Meeting |
|
|
1730-1740 |
|
|
|
1740-1750 |
|
|
|
1750-1800 |
|
|
|
1800-1810 |
|
|
|
1810-1820 |
|
|
|
1730-1740 |
|
|
|
1740-1750 |
|
|
|
1750-1800 |
|
|
|
1800-1810 |
|
|
|
1810-1820 |
|
|
|
1820-1830 |
|
|
|
1830-1840 |
|
|
|
1840-1850 |
|
|
